Cambrian Biopharma Investor

Cambrian is a distributed development company building therapeutics to lengthen health span.
Technology: Cell_Therapies, Geroscience
Industry: Biopharma, Biotechnology, Life Science
Headquarters: New York, New York, United States
Founded Date: 2019-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investor Type: For Profit
Investment Stage: Early Stage Venture
Number Of Exits: 2
Investors Number: 16
Total Funding: 160000000
Last Funding Date: 2021-10-26
Last Funding Type: Series C

Visit Website
press@cambrianbio.com
https://twitter.com/cambrianbio
Register and Claim Ownership